SOCIAL AVOIDANT BEHAVIOUR side effect
What is SOCIAL AVOIDANT BEHAVIOUR ?Drugs associated with SOCIAL AVOIDANT BEHAVIOUR
ATOMOXETINE CHAMPIX CHANTIX CONCERTA EQUASYM HALOPERIDOL MIRAPEX RISPERDAL SEROQUEL TIOTROPIUM VARENICLINE VYVANSE XYREM ZYPREXASOCIAL AVOIDANT BEHAVIOUR : Seroquel Side Effects Report #5460519-1
Physician from UNITED STATES reported SEROQUEL problem on July 26, 2007. Male patient, 29 years of age, was diagnosed with bipolar i disorder and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: social avoidant behaviour, symptom masked, . SEROQUEL dosage: unknown. During the same period patient was treated with LITHIUM, ZYPREXA. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5628703-1
CHANTIX problem was reported by a Health Professional from UNITED KINGDOM on Feb 05, 2008. Male patient, 74 years of age, weighting 153.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: depression, social avoidant behaviour, . CHANTIX dosage: unknown. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Equasym Side Effects Report #5603390-7
Consumer or non-health professional from GERMANY reported EQUASYM problem on Jan 03, 2008. Male patient, weighting 70.55 lb, was treated with EQUASYM. After drug was administered, patient experienced the following problems/side effects: sleep disorder, social avoidant behaviour, tic, . EQUASYM dosage: 20 MG 1/D. During the same period patient was treated with METHYLPHENIDATE. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Vyvanse Side Effects Report #5597785-8
VYVANSE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 22, 2007. Male patient, child 7 years of age, weighting 50.04 lb, was treated with VYVANSE. After drug was administered, patient experienced the following problems/side effects: depressed mood, social avoidant behaviour, . VYVANSE dosage: 50 MG, ORAL. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Tiotropium Side Effects Report #5524022-2
Physician from reported TIOTROPIUM problem on Nov 16, 2007. Female patient, 82 years of age, weighting 198.0 lb, was diagnosed with chronic obstructive pulmonary disease, arthritis, hypertension, dyspepsia and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: depression, social avoidant behaviour, . TIOTROPIUM dosage: unknown. During the same period patient was treated with FLUTICASONE PROPIONATE, GLUCOSAMINE, LISINOPRIL, OMEPRAZOLE, PARACETAMOL. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Mirapex Side Effects Report #5467520-2
MIRAPEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient was treated with MIRAPEX. After drug was administered, patient experienced the following problems/side effects: social avoidant behaviour, weight increased, . MIRAPEX dosage: unknown. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5389532-X
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on July 05, 2007. Female patient, weighting 140.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: depression, social avoidant behaviour, . CHANTIX dosage: unknown. During the same period patient was treated with EFFEXOR, WELLBUTRIN, SEROQUEL, KLONOPIN, DIOVAN HCT, LOPRESSOR, PLENDIL, ADVAIR DISKUS. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Risperdal Side Effects Report #5397620-7
RISPERDAL problem was reported by a Physician from BELGIUM on July 18, 2007. Male patient, child 12 years of age, was diagnosed with autism, abnormal behaviour and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: anxiety, social avoidant behaviour, . RISPERDAL dosage: unknown. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5389532-X
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on July 05, 2007. Female patient, weighting 140.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: depression, social avoidant behaviour, . CHANTIX dosage: unknown. During the same period patient was treated with EFFEXOR, WELLBUTRIN, SEROQUEL, KLONOPIN, DIOVAN HCT, LOPRESSOR, PLENDIL, ADVAIR DISKUS. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Risperdal Side Effects Report #5397620-7
RISPERDAL problem was reported by a Physician from BELGIUM on July 18, 2007. Male patient, child 12 years of age, was diagnosed with autism, abnormal behaviour and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: anxiety, social avoidant behaviour, . RISPERDAL dosage: unknown. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5659636-2
Pharmacist from UNITED STATES reported CHANTIX problem on Mar 10, 2008. Female patient, 52 years of age, weighting 269.4 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: crying, mood altered, social avoidant behaviour, . CHANTIX dosage: 1MG BID PO. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Xyrem Side Effects Report #5619286-0
XYREM problem was reported by a Consumer or non-health professional from CANADA on Jan 28, 2008. Female patient, 77 years of age, was diagnosed with cataplexy and was treated with XYREM. After drug was administered, patient experienced the following problems/side effects: hallucination, visual, nausea, social avoidant behaviour, . XYREM dosage: 4.5 GM (2.25 GM, 2 IN 1 D), ORAL; 6 MG (3 GM, 2 IN 1 D), ORAL. During the same period patient was treated with TOLTERODINE TARTRATE, IBUPROFEN, AMLODIPINE BESYLATE, VITAMIN D. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Haloperidol Side Effects Report #5620031-3
Physician from SOUTH AFRICA reported HALOPERIDOL problem on Dec 18, 2007. Female patient, 34 years of age, was diagnosed with psychotic disorder, major depression and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: depressed mood, influenza like illness, social avoidant behaviour, toxic epidermal necrolysis, . HALOPERIDOL dosage: unknown. During the same period patient was treated with RISPERIDONE, FLUOXETINE. Patient was hospitalized. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Equasym Side Effects Report #5603389-0
EQUASYM problem was reported by a Consumer or non-health professional from GERMANY on Jan 03, 2008. Female patient was treated with EQUASYM. After drug was administered, patient experienced the following problems/side effects: apathy, fatigue, social avoidant behaviour, tic, . EQUASYM dosage: 10 MG /D. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5605283-8
Health Professional from UNITED KINGDOM reported CHANTIX problem on Jan 21, 2008. Female patient, weighting 154.3 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: depression, panic reaction, social avoidant behaviour, tearfulness, . CHANTIX dosage: unknown. During the same period patient was treated with AMOXICILLIN, METRONIDAZOLE. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Vyvanse Side Effects Report #5606873-9
VYVANSE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2008. Male patient, child 7 years of age, weighting 399.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with VYVANSE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anorexia, social avoidant behaviour, suicidal ideation, . VYVANSE dosage: 30 MG, 1X/DAY:QD, ORAL. During the same period patient was treated with VITAMINS NOS. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Vyvanse Side Effects Report #5610668-X
Consumer or non-health professional from UNITED STATES reported VYVANSE problem on Jan 14, 2008. Male patient, child 7 years of age, weighting 44.09 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with VYVANSE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anorexia, social avoidant behaviour, suicidal ideation, victim of crime, . VYVANSE dosage: 70 MG, 1X/DAY;QD, ORAL. During the same period patient was treated with VITAMIN NOS. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Risperdal Side Effects Report #5504116-8
RISPERDAL problem was reported by a Physician from GERMANY on Oct 31, 2007. Male patient, 54 years of age, was diagnosed with schizophrenia, disorganised type and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: anxiety, sensory disturbance, social avoidant behaviour, . RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5522510-6
Physician from UNITED STATES reported CHANTIX problem on Nov 08, 2007. Female patient, 21 years of age, was diagnosed with ex-smoker and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: depression, self injurious behaviour, social avoidant behaviour, suicidal ideation, . CHANTIX dosage: unknown. During the same period patient was treated with CLARINEX. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Zyprexa Side Effects Report #5541804-1
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Male patient, 22 years of age, weighting 115.1 lb, was diagnosed with schizophrenia, paranoid type and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: hallucination, overdose, social avoidant behaviour, weight increased, . ZYPREXA dosage: 15 MG, 2/D, ORAL. During the same period patient was treated with DEPAKOTE, ALPRAZOLAM. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Champix Side Effects Report #5476397-0
Health Professional from UNITED KINGDOM reported CHAMPIX problem on Sept 21, 2007. Female patient, 60 years of age, was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: nervousness, paranoid personality disorder, social avoidant behaviour, . CHAMPIX dosage: unknown. During the same period patient was treated with PROZAC, NICORETTE. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Chantix Side Effects Report #5486998-1
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Female patient, 66 years of age, weighting 175.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: anger, depression, social avoidant behaviour, suicidal ideation, . CHANTIX dosage: unknown. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Risperdal Side Effects Report #5500881-4
Physician from GERMANY reported RISPERDAL problem on Oct 25, 2007. Male patient, 54 years of age, was diagnosed with schizophrenia, disorganised type and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: anxiety, sensory disturbance, social avoidant behaviour, . RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Champix Side Effects Report #5501100-5
CHAMPIX problem was reported by a Health Professional from UNITED KINGDOM on Oct 17, 2007. Female patient, 49 years of age, was diagnosed with pain, thyroid pain, thyroid disorder and was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: depression, nausea, social avoidant behaviour, suicidal behaviour, suicidal ideation, . CHAMPIX dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, BUPRENORPHINE, FUROSEMIDE, LEVOTHYROXINE. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Varenicline Side Effects Report #5442459-7
Consumer or non-health professional from UNITED KINGDOM reported VARENICLINE problem on Aug 23, 2007. Female patient, 60 years of age, was diagnosed with hypertension, menopause and was treated with VARENICLINE. After drug was administered, patient experienced the following problems/side effects: depression, personality change, social avoidant behaviour, somnolence, . VARENICLINE dosage: unknown. During the same period patient was treated with BENDROFLUMETHIAZIDE, GAMOLENIC ACID. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Risperdal Side Effects Report #5464417-9
RISPERDAL problem was reported by a Physician from GERMANY on Sept 14, 2007. Male patient, 54 years of age, was diagnosed with schizophrenia, disorganised type and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: anxiety, sensory disturbance, social avoidant behaviour, . RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Atomoxetine Side Effects Report #5468278-3
Physician from UNITED KINGDOM reported ATOMOXETINE problem on Sept 14, 2007. Male patient, 13 years of age, weighting 80.25 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ATOMOXETINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, disorientation, social avoidant behaviour, speech disorder, . ATOMOXETINE dosage: 40 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Concerta Side Effects Report #5397836-X
CONCERTA problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Female patient, 22 years of age, weighting 165.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with CONCERTA. After drug was administered, patient experienced the following problems/side effects: depression, self-injurious ideation, social avoidant behaviour, suicidal ideation, . CONCERTA dosage: unknown. Patient recovered.
SOCIAL AVOIDANT BEHAVIOUR : Concerta Side Effects Report #5397836-X
Consumer or non-health professional from UNITED STATES reported CONCERTA problem on July 24, 2007. Female patient, 22 years of age, weighting 165.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with CONCERTA. After drug was administered, patient experienced the following problems/side effects: depression, self-injurious ideation, social avoidant behaviour, suicidal ideation, . CONCERTA dosage: unknown. Patient recovered.